Protas

Season’s greetings to our colleagues, partners and followers ✨ We’re so proud of what we’ve achieved together in 2024, as we continue our mission of transforming clinical trials for the benefit of patients everywhere. From everyone at Protas, we wish you a fabulous festive season with family, friends and loved ones, and we look forward to the new year ahead.

Congratulations Chloe Jane Fox for being picked as Revolent Group's "Revol of the Year" 👏 We’re so grateful for the amazing Revols we work with – and to Revolent for teaming us up with such fantastic tech talent. Thanks to Chloe and the rest of our Revols: Bethany Bayliss Jared Lelos Lauren Wakefield Maheen Khurram Poonam Y.

How do we move from understanding there were lessons to be learnt from the pandemic in how to improve clinical trial design and delivery to actually implementing them? As Head of The Good Clinical Trials Collaborative, Nick Medhurst and his team work with organisations globally to enable good clinical trials. But what makes a trial “good”? What does the future of best practice look like? Discover more about how the Collaborative is helping organisations to design and deliver good trials, and why five principles hold the key to promising new innovations in healthcare. “Due to COVID-19, clinical trials at that time were front page news globally. Why can’t clinical trials go faster? Why can’t we get better information? What counts as good-quality evidence? The pandemic starkly illustrated just how critical sufficiently large, randomised trials are. “The challenge now is in how to continue the momentum to transform clinical trials – which is fundamental to both the Collaborative and Protas.” Read the full interview here: https://lnkd.in/eqECCr4Q To find out more about the Collaborative, visit: www.goodtrials.org #ProtasPeople #LifeAtProtas #ClinicalTrials #Covid

Major policy milestones to round out an exciting year at Protas 📣 Collaborative policy development is critical to our mission of tackling the burden of common disease worldwide by transforming clinical trials. This year, we’ve helped to shape policy efforts in the UK and globally – which signal promising change in how large trials are designed and delivered for the benefit of patients. We’ve contributed to: 1️⃣ Legislation tabled at UK parliament to reform clinical trial regulation – the largest overhaul in 20 years 2️⃣ A 10-Year Health Plan to enable NHS England to become “fit for the future” 3️⃣ World Health Organization's new guidance for best practices in clinical trials, which incorporates the work of our colleagues at The Good Clinical Trials Collaborative Read more here: https://lnkd.in/gJJaVb-p And let’s continue to build on this momentum together in 2025! #ClinicalTrials #healthcare #healthpolicy

Continuing our Protas People series, this week’s spotlight is on William Hayes, our Drug Supply Manager 💊    William leads in the design and delivery of a drug supply plan that supports Protas’ mission of delivering efficient and impactful trials.    “It is such a privilege to work at a company that is full of people passionate about improving the landscape of clinical trials, where I can see the real-world impact of my work.”    Visit our website to read more about our mission and work: www.protas.co.uk     #ProtasPeople #LifeAtProtas #ClinicalTrials #SupplyChainManagement  

As our Chief Information Officer, Stefan Thorbjørn Blixen-Finecke leads IT, Technology, Information Security and Information Governance at Protas.    Together, these teams ensure that our clinical trials are not only robust, efficient and secure, but are on track to deliver high-quality, impactful results.    “At Protas our greatest strength is our incredible team and a sense of purpose in driving much-needed change in clinical trial design and delivery.     “By integrating good guidance, smart design and innovative technology, we create smarter, better and more affordable trials to find treatments for common diseases.”    Find out more about us at www.protas.co.uk     #ProtasPeople #LifeAtProtas #ClinicalTrials #InnovationInHealth 

Simply having a wonderful Christmas time ✨    From Northumberland to Brighton and everywhere in between, earlier this week our team gathered at Manchester Hall for our annual festive get-together.    Our vision is to transform clinical trials – and it’s our people who are at the heart of turning it into a reality.    Thank you Team Protas… and to everyone on the journey with us. #GreatPlacetoWork #FeelingFestive #ChristmasParty #HolidaySeason #Community #Collaboration #Respect

Dr Michelle Pipe is a Research Physician in our Science Team 🩺    She plays a pivotal role in trial protocol design and delivery plans, ensuring that every study we undertake is scientifically rigorous and aligned with our mission of smarter trials for better health.    Her expertise bridges the gap between innovative trial concepts and practical, effective delivery, working across teams to ensure trials are set up for success.    “Collaborating with likeminded individuals to work together towards our common goal of delivering better trials for common diseases, with the aim of improving the health of the population, is extremely rewarding.     “The culture and ethos at Protas really resonate with me, and I'm excited to see what the future holds!”    Find out about the people driving our mission at Protas: https://lnkd.in/e9wAmsty    #ProtasPeople #LifeAtProtas #ResearchExcellence #ClinicalTrials 

In this week’s Protas People spotlight, we’re featuring Omar Latif, Head of Technology Operations at Protas 🚀 Omar leads the team that ensures our technological infrastructure is robust, innovative and aligned with our mission of designing smarter clinical trials. “Technology is at the heart of modern clinical trials, enabling us to work smarter, faster and more effectively. “I’m proud to lead a team that challenges the status quo – driving innovation and ensuring we have the tools to deliver meaningful improvements to public health.” Stay tuned for more stories from the people at Protas. #ProtasPeople #LifeAtProtas #HealthTechnology

Clinical trials that are founded on good guidelines are crucial for producing successful, informative medical research.    Prof Sir Martin Landray (Chief Executive at Protas and Senior Lead at The Good Clinical Trials Collaborative) shares how global guidelines promote and support informative, ethical and efficient clinical trials.    Key focus areas are:    💰Trial efficiencies: “Randomised trials are fundamental to knowing which treatments work and which don’t.” But the costs and complexity of running these trials have skyrocketed, meaning efficiency is critical.    🔬Quality: “Many of the guidelines and rules have constrained the ability of trials to adapt to a changing world.” Written decades ago, these guidelines often miss the mark on focusing on the core principles of what truly matters in a trial.    📃Good guidelines: “Good guidelines are needed to facilitate reliable answers to important questions about the benefits and hazards of medical interventions.” Simplifying and re-evaluating existing guidelines is crucial for a more agile and effective trial ecosystem.     Working shoulder to shoulder with leading international bodies and experts, Protas and the Good Clinical Trials Collaborative are focused on creating a system that makes good trials easier to do.     To find out more about us, visit www.protas.co.uk    #ClinicalTrials #GlobalHealth #MedicalResearch #HealthcareInnovation